RNRMarketResearch.com

Global Mice Model Market Competitive Landscape & Forecast to 2018

Press Release   •   Sep 27, 2014 05:17 EDT

The mice model market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018. RNR presents analysis and discussion about mice model market, its forecasts and more is now available in the global research report “Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018”. This report can be ordered at ReportsnReports.com.

Over the years, the mice model market, which includes models and services, has witnessed many innovations that have led to an increase in the application areas of mice models. For instance, mice models are widely used in preclinical research in a number of academic institutions all around the world and also in various industries including pharmaceutical, biotechnology, biopharmaceutical, medical research, biomedical research, and others.

The inbred mice market is the fastest-growing segment of the mice model market. The rapid growth of this market is attributed to their ability to reproduce the same results in different laboratories over a period of time. However, the knockout mice model market is the fastest-growing market due to the increase in the number of investments in the development of knockout mice models. One of the major investments includes $110 million by the National Institutes of Health (NIH) (U.S.) for a period of five years to initiate the second phase of the Knockout Mouse Project (KOMP2) in September 2011.

In the mice model services market, the breeding market is expected to grow at the highest CAGR. This is due to the increase in the production of mice as well as the increase in use of mice by companies, which has increased the need to manage the breeding of these mice in an effective manner. Thus, the growing market for mice models is likely to boost the market for breeding services.

In the coming years, the growth of the mice model market is likely to be focused on China, India, Japan, Brazil, and Mexico. These countries offer a wide array of opportunities for growth and are likely to serve as revenue pockets for the mice model market. All these countries offer high-growth potential as compared to mature markets such as the U.S. and U.K.

Complete report available at http://www.reportsnreports.com/reports/272287-mice-model-market-by-type-inbred-knockout-conditioned-technology-microinjection-embryonic-stem-cell-disease-oncology-immunology-cns-service-breeding-cryopreservation-quarantine-care-products-cages-bedding-feed-forecasts-to-2018.html .

Growth in these markets is spurred by the growing R&D activities in China, Japan, Brazil, and Singapore. In addition to this, the Asian countries have low presence of animal welfare activities conducted by animal activists and thus are potential regions to outsource animal models and allied animal testing services. Thus, the Asian region is more adaptive and business friendly due to the comparatively less stringent regulations. This has led to an increase in R&D activities in this region. The region is a hub for preclinical trials and has witnessed a high growth in the CRO industry in China, India, Korea, and Taiwan. According to ClinicalTrials.gov, the number of clinical trials conducted in India was 40 to 50 in 2003, which increased to 270 by 2007. China, on the other hand, surpassed India and showcased 428 ongoing trials in 2008 and a total of 870 trials (including completed and ongoing) as compared to 737 trials in India by 2008. Additionally, clinical trials are expected to be up to 50% cheaper in India compared to the U.S. Thus, the growth in R&D activities is propelling the demand for mice models.

The mice model market is highly competitive and has few major companies dominating the market. Players operating in the market strive hard to gain market visibility and a larger market share. Companies primarily focus on strategies such as agreements, partnerships, collaborations, joint ventures, and mice model out-licensing in order to increase their customer base. However, the stringent laws and regulations for the ethical use of laboratory animals are limiting the use of these mice models.

The report extensively covers mice models and services and mice care products used in a number of life sciences industries. Volume analysis of the market has not been provided due to wide variations in prices of mice models, which vary with different indications.

Inquire for discount @ http://www.reportsnreports.com/contacts/Discount.aspx?name=272287 . (Original Price US $4650 for single user)


Table of Contents for “Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018” research report includes:

1 Introduction

2 Executive Summary

3 Market Dynamics

4 Market Share Analysis, By Key Players

5 Mice Model Market Size

6 Geographic Analysis

7 Competitive Landscape

8 Company Profiles

9 Preclinical Pipeline

10 Industry Speaks

11 Cost Assessment and Mouse Model Outlicensing/Buyer Companies Assessment

List Of Figures

Figure 1 Global Mice Model Market Segmentation

Figure 2 Key Stakeholders

Figure 3 Research Methodology- Market Size Estimation

Figure 4 Research Methodology- Market Sizing

Figure 5 Research Methodology- Competitive Assessment

Figure 6 Research Methodology- Data Triangulation

Figure 7 Research Methodology- Secondary Research Procedure

Figure 8 Global Mice Model Market, By Type, 2013 ($Million)

Figure 9 Global Market, By Services, 2013 ($Million)

Figure 10 Global Market, By Geography, 2013 ($Million)

Figure 11 Market Share, By Company (in Terms of $Value), 2013

Figure 12 Competitive Positioning, By Company (2010 – 2013)

Figure 13 Mice Model Market (Inclusive of Models and Services, Based On Value, 2012)

Figure 14 Mice Model Market Segmentation, By Type

Figure 15 Inbred and Knockout Mice Model Market, $Million (2013 – 2018)

Figure 16 Mice Model Market Segmentation, By Technology 103

Figure 17 Microinjection and Embryonic Stem Cell Based Mice Model Market, $Million (2013 – 2018)

Figure 18 Mice Model Market, By Disease

Figure 19 Oncology and Immunology and Inflammation Mice Model Market, 2013 – 2018 ($Million)

Figure 20 Mice Model Market Segmentation, By Service

Figure 21 Inbred and Knockout Mice Model Market, $Million (2013 - 2018)

Figure 22 Comparison of Global Mice Model Market By Services, By Geography (For The Year 2013 and 2018)

Figure 23 Mice Care Products Market, By Segment

Figure 24 Cages and Feed Market, $Million (2013 - 2018)

Figure 25 Comparison of Global Mice Care Products Market, By Geography (For The Year 2013 and 2018)

Figure 26 Tapped/Matured and Untapped/Potential Markets

Figure 27 Mice Model Market, By Geography

Figure 28 Mice Model Market Geographic Analysis

Figure 29 Scientific R&D Spending, By Country

Figure 30 Competitive Developments Mapping (top Five Players For Each Key Growth Strategy)

Figure 31 Share of Key Strategies (2010 – 2013

Figure 32 Most Active Companies (2010 – 2013)

Figure 33 Share of Agreements, Partnerships, Collaborations, and Joint Ventures (2010– 2013)

Figure 34 Share of Licensing (2010–2013)

Figure 35 Share of Grants and Funds (2010 – 2013)

Figure 36 Share of Marketing and Promotion (2010 – 2013)

Figure 37 Share of Expansions (2010 – 2013)

Figure 38 Share of Patents (2010 – 2013)

Figure 39 Share of New Product Launches (2010 – 2013)

Figure 40 Share of Others (2010 – 2013)

Figure 41 Ablexis Llc : Geographic Presence

Figure 42 Ablexis Llc : Strategy

Figure 43 Charles River Laboratories, Inc.: Geographic Presence

Figure 44 Charles River Laboratories, Inc.: total Revenue, 2010 – 2012 ($Million )

Figure 45 Charles River Laboratories, Inc.: total Revenue, By Segment, 2010 – 2012 ($Million )

Figure 46 Charles River Laboratories, Inc.: Total Revenue, By Geography, 2010 – 2012 ($Million )

Figure 47 Covance, Inc.: Geographic Presence

Figure 48 Covance, Inc.: Total Revenue, 2010 – 2012 ($Million )

Figure 49 Covance, Inc.: Total Revenue, By Segment, 2010 – 2012 ($Million )

Figure 50 Covance, Inc.: Total Revenue, By Geography, 2010 – 2012 ($Million )

Figure 51 Crescendo Biologics: Geographic Presence

Figure 52 Crescendo Biologics: Strategy

Figure 53 Deltage N, Inc.: Geographic Presence

Figure 54 Deltagen, Inc.: Total Revenue, 2010 – 2012 ($Million )

Figure 55 Deltage N, Inc.: Strategy

Figure 56 Genoway S.A.: Geographic Presence

Figure 57 Genoway S.A.: Total Revenue, 2010 – 2012 ($Million )

Figure 58 Genoway S.A.: Total Revenue, By Geography, 2010 – 2012 ($Million )

Figure 59 Genoway S.A.: Strategy

Figure 60 Harbour Antibodies Bv : Geographic Presence

Figure 61 Harbour Antibodies Bv : Strategy

Figure 62 Harlan Laboratories, Inc. : Geographic Presence

Figure 63 Harlan Laboratories, Inc. : Strategy

Figure 64 Immunogenes Ag : Geographic Presence

Figure 65 Immunogenes Ag : Strategy

Figure 66 Ingenious Targeting Laboratory : Geographic Presence

Figure 67 Ingenious Targeting Laboratory : Stratgey

Figure 68 Lexicon Pharmaceuticals : Geographic Presence

Figure 69 Lexicon Pharmaceuticals : Total Revenue, 2010 – 2012 ($Million )

Figure 70 Lexicon Pharmaceuticals : Total Revenue, By Segment, 2010 – 2012 ($Million )

Figure 71 Lexicon Pharmaceuticals : Strategy

Figure 72 Mirimus : Geographic Presence

Figure 73 Mirimus : Strategy

Figure 74 Sage Labs : Geographic Presence

Figure 75 Sage Labs : Strategy

Figure 76 Taconic Farms : Geographic Presence

Figure 77 Taconic Farms : Strategy

Figure 78 The Jackson Laboratory : Geographic Presence

Figure 79 The Jackson Laboratory : Total Revenue, 2010 – 2012 ($Million )

Figure 80 The Jackson Laboratory : Total Revenue, By Segment, 2010 – 2012 ($Million )

Figure 81 The Jackson Laboratory : Strategy

Figure 82 Immunodeficient and Humanized Mouse Model Development Timeline

Figure 83 Transgenic, Inc. : Geographic Presence

Figure 84 Transgenic, Inc. : Strategy

Figure 85 Colony Maintenance Types and Levels

Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=272287 . (This is a premium research report priced at US$ 4650 for single user PDF license).


About Us:

ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. This comprehensive collection of market research reports include market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. Our research specialists & industry experts, through our market research offerings, ensure we deliver on all your business & industry research requirements - first time and every time!